2025年1月7日 · Eprex or exogenous epoetin alfa binds to the erythropoietin receptor (EPO-R) and activates intracellular signal transduction pathways . The affinity (Kd) of EPO for its receptor on human cells is ∼100 to 200 pM .

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. [1] . They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. [1][2] In these situations they decrease the need for blood transfusions. [2] .

2017年3月24日 · EPREX ® (epoetin alfa) is an erythreopoiesis-stimulating agent (ESA) that works by stimulating the production of red blood cells (RBCs). 6 ESAs are an important treatment option for patients with certain types of anaemia, including chemotherapy-induced anaemia and anaemia due to chronic kidney disease.

inge. EPREX® is a sterile, preservative-free buffered protein solution of epoetin alfa (rch) in pre-filled syr. nges. The pre-filled syringes are fitted with the PROTECSTM needle guard d. e. 2. QUALITATIVE AND QUANTITATIVE COMPO. ITION Epoetin alfa (r-HuEPO CHO), produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA techn.

2025年2月4日 · Eprex 40000 IU/ml solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

2019年6月1日 · EPREX ® (Epoetin Alfa) Marketing Authorisation Extended to Include Treatment of Symptomatic Anaemia in Patients With Low or intermediate-1-risk Myelodysplastic Syndromes

Eprex: Epoetin alfa belongs to the class of medications known as erythropoiesis regulating hormones. It is used to increase the production of red blood cells and decrease the need for transfusions of red blood cells.

EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. EPREX can reduce the need for a blood transfusion in these patients.

2025年2月26日 · Ce médicament contient de l'époétine, une substance identique à l'érythropoïétine (EPO) humaine, produite par biotechnologie. Elle stimule la production des globules rouges par la moelle osseuse. Elle permet de corriger certaines anémies et de limiter ainsi le recours aux transfusions sanguines lorsque l'anémie est mal supportée.

2025年1月24日 · EPREX vous est prescrit pour stimuler votre moelle osseuse afin de produire plus de globules rouges. · EPREX est utilisé dans le traitement de l’anémie chez les adultes recevant une chimiothérapie pour des tumeurs solides, un lymphome malin ou un myélome multiple (cancer de la moelle osseuse) et pouvant avoir besoin d’une transfusion ...